Subject(s)
Drug Resistance, Bacterial , Meningitis, Pneumococcal/drug therapy , Meningitis, Pneumococcal/prevention & control , Pneumococcal Vaccines/administration & dosage , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/immunology , Vaccines, Conjugate/pharmacology , Anti-Bacterial Agents/pharmacology , Child, Preschool , Epidemiological Monitoring , Female , Humans , Infant , Infant, Newborn , Israel/epidemiology , Male , Meningitis, Pneumococcal/epidemiology , Microbial Sensitivity Tests , Pneumococcal Vaccines/immunology , Pneumococcal Vaccines/pharmacology , Population Surveillance , Streptococcus pneumoniae/isolation & purification , Vaccines, Conjugate/immunologyABSTRACT
OBJECTIVES: To implement a residency-based program for the teaching of evidence-based medicine in an Israeli HMO and to incorporate this effort into the HMO's routine drug policy formulation process. METHODS: Residents and preceptors participating in the family practice residency program in The Leumit Health Fund, 1 of the 4 HMOs operating in Israel, were invited to participate in a workshop for the formulation of guidelines for antibiotic treatment of the common infectious diseases encountered in primary care. The participants were allocated to teams consisting of a preceptor (an attending physician) and a resident physician, with each team choosing a different disease to analyze. Upon completion of the program, a questionnaire was sent to all residents and preceptors who participated in the workshop to evaluate attitudes concerning the outcomes of the program. RESULTS: Guidelines for the treatment of 14 infectious diseases commonly seen in the primary care setting were formulated. The program was accepted by the participants, who ultimately cooperated with the relevant HMO stakeholders in the formulation of official HMO policies for drug prescribing. CONCLUSION: The utilization of family practice residents is a feasible method of formulating in-house clinical practice guidelines for a managed care setting. The program was mutually beneficial for both the residents and for the stakeholders in the HMO.